Bu öğeden alıntı yapmak, öğeye bağlanmak için bu tanımlayıcıyı kullanınız:
http://hdl.handle.net/11452/30434
Başlık: | Which is worse? Comparison of ART outcome between women with primary or recurrent endometriomas |
Yazarlar: | Ata, Barış Namusoğlu, Sezcan Seyhan, Ayşe Kaspoğlu, Işıl Urman, Bülent Bozdağ, Gürkan Uludağ Üniversitesi/Tıp Fakültesi/Kadın Hastalıkları ve Doğum Anabilim Dalı. 0000-0002-9277-7735 Aslan, Kiper Avcı, Berrin Uncu, Gürkan AER-7173-2022 AAH-9694-2021 ABE-6685-2020 AAT-3479-2021 56740498500 55769899600 6603716169 |
Anahtar kelimeler: | Obstetrics & gynecology Reproductive biology Assisted reproduction Endometriosis Infertility Live birth Ovarian reserve Necurrent endometrioma Ovarian reserve Impact Excision Ivf Surgery Removal Cycles |
Yayın Tarihi: | 3-May-2017 |
Yayıncı: | Oxford University |
Atıf: | Ata, B. vd. (2017). ''Which is worse? Comparison of ART outcome between women with primary or recurrent endometriomas''. Human Reproduction, 32(7), 1427-1431. |
Özet: | Are live birth rates (LBR) different after ART cycles between women with primary or recurrent endometrioma? Women with recurrent endometrioma have similar LBR as compared to patients with primary endometrioma. Recurrence rate can be as high as 29% after endometrioma excision. Prior studies on management of endometrioma before ART involve primary endometriomas. There is limited information regarding the prognosis of women with recurrent endometriomas. A multicenter retrospective cohort study, including 76 women with primary and 82 women with recurrent endometriomas treated at the participating centers over a 6-year period. Women with endometrioma who underwent ART at three academic ART centers. Couples with another indication for ART were excluded. Female age, median number of prior failed ART cycles, proportion of patients with bilateral endometrioma (28 versus 28.9%), ovarian stimulation protocols, and total gonadotropin consumption were similar between the study groups. Numbers of metaphase two oocytes (5 versus 6), number of embryos transferred, and the proportion of patients undergoing blastocyst transfer were similar across the study groups. Clinical pregnancy rates (36.6 versus 34.2%, absolute difference 2.4%, 95% CI: -12.5 to 17.3%, P = 0.83) and LBR (35.4 versus 30.3%, absolute difference 5.1%, 95% CI: -9.5 to 19.7%, P = 0.51) per started cycle in recurrent and primary endometrioma were similar. Comparable success rates were also confirmed with logistic regression analysis (OR: 1.14, 95% CI: 0.78-0.57, P = 2.3) The retrospective design has inherent limitations. Some women with severely decreased ovarian reserve after primary endometrioma excision may not have pursued further treatment. The management of endometrioma prior to ART is controversial but a different management strategy is not required for recurrent endometriomas. Since recurrent endometriomas do not have a worse impact on ART outcome than primary endometriomas, and repeat surgery has a higher risk for complications, conservative management without surgery can be justified. |
URI: | https://doi.org/10.1093/humrep/dex099 https://academic.oup.com/humrep/article/32/7/1427/3819244 1460-2350 http://hdl.handle.net/11452/30434 |
ISSN: | 0268-1161 |
Koleksiyonlarda Görünür: | Scopus Web of Science |
Bu öğenin dosyaları:
Dosya | Açıklama | Boyut | Biçim | |
---|---|---|---|---|
Eslan_vd_2017.pdf | 145.08 kB | Adobe PDF | Göster/Aç |
Bu öğe kapsamında lisanslı Creative Commons License